AIFarm, Ltd. (AIFM)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
AIFarm, Ltd. (AIFM) trades at $0.00 with AI Score 46/100 (Grade C). AIFarm, Ltd. is a development stage company specializing in custom biodome design and construction for commercial and local agricultural producers. Market cap: $2,079, Sector: Industrials.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for AIFM: AIFM does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates AIFM against Industrials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
AIFM: the 1 perspectives are evenly split.
How is this calculated? →AIFarm, Ltd. (AIFM) Industrial Operations Profile
AIFarm, Ltd. is a development stage company focused on designing and building custom biodomes for agricultural applications globally. Operating in the Agricultural-Machinery industry, AIFarm caters to both commercial and small-scale producers, offering tailored growing systems from its base in Hong Kong.
What Is the Investment Thesis for AIFM?
AIFarm, Ltd. presents a high-risk, high-reward investment opportunity given its development stage and focus on the emerging biodome market. The company's potential lies in its ability to capitalize on the growing demand for sustainable and efficient agricultural solutions. However, investors should be aware of the significant risks associated with investing in a development stage company, including limited operating history, reliance on future funding, and intense competition. The company's success hinges on its ability to secure funding, execute its business plan, and gain market share in the competitive agricultural technology landscape. With a market capitalization of 2K and negative P/E ratio, AIFarm's financial viability remains uncertain.
Based on FMP financials and quantitative analysis
AIFM Key Highlights
- AIFarm, Ltd. is a development stage company specializing in biodome design and construction.
- The company targets both commercial and small local agricultural producers.
- AIFarm's proprietary growing system aims to optimize growing conditions for year-round crop production.
- The company changed its name from Eco Energy Tech Asia, Ltd. in January 2020.
- AIFarm is based in Kowloon, Hong Kong, and has a small team of 3 employees.
Who Are AIFM's Competitors?
AIFM is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CEAD CEA Industries Inc. | $10.00 | +29.87% | $8.02M | 63 |
| NKLA Nikola Corporation | $0.18 | +0.00% | $15.46M | 60 |
| DE Deere & Company | $635.24 | +2.25% | 172B | 52 |
| SNYYF Sany Heavy Equipment International Holdings Company Limited | $0.91 | +2.43% | $2.99B | 52 |
| AUSTF Austin Engineering Limited | $0.13 | +0.00% | $77.89M | 46 |
| CLEV Concrete Leveling Systems, Inc. | $0.75 | -0.01% | $10.52M | 46 |
| AGCO AGCO Corporation | $118.34 | +1.59% | $8.57B | 46 |
| SHKLF Sinotruk (Hong Kong) Limited | $3.38 | +0.00% | $9.33B | 46 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are AIFM's Key Strengths?
- Proprietary biodome design and construction expertise
- Customization capabilities to meet diverse client needs
- Focus on sustainable and efficient agricultural practices
- Potential to capitalize on the growing demand for CEA solutions
What Are AIFM's Weaknesses?
- Development stage company with limited operating history
- Reliance on future funding to support growth
- Small team size and limited resources
- Lack of established brand recognition
What Could Drive AIFM Stock Higher?
- Potential partnerships with agricultural companies to expand market reach.
- Development and launch of advanced biodome technologies.
- Increasing demand for sustainable agriculture solutions.
- Government incentives and subsidies for CEA projects.
What Are the Key Risks for AIFM?
- Weak fundamentals — a Piotroski F-Score of 0/9 flags soft profitability, leverage or efficiency.
- Limited access to capital and funding.
- Intense competition from established players in the agricultural technology market.
- Economic downturns that could reduce demand for agricultural investments.
- Dependence on key personnel and expertise.
What Are the Growth Opportunities for AIFM?
- Expansion into New Geographic Markets: AIFarm has the opportunity to expand its reach beyond its current base in Hong Kong by targeting new geographic markets with high demand for sustainable agriculture solutions. This includes regions with limited arable land, harsh climates, or a strong focus on local food production. By establishing partnerships with local distributors or setting up regional offices, AIFarm can tap into new customer segments and increase its revenue streams. The global market for controlled environment agriculture (CEA) is projected to reach $98.39 billion by 2030, presenting a significant growth opportunity for AIFarm.
- Development of Advanced Biodome Technologies: AIFarm can invest in research and development to create more advanced biodome technologies that further optimize growing conditions, reduce energy consumption, and improve crop yields. This includes incorporating features such as automated climate control, precision irrigation, and LED lighting systems. By offering cutting-edge biodome solutions, AIFarm can differentiate itself from competitors and attract customers seeking the most efficient and sustainable growing systems. The market for agricultural technology is rapidly evolving, with continuous advancements in areas such as sensors, data analytics, and automation.
- Partnerships with Research Institutions and Universities: Collaborating with research institutions and universities can provide AIFarm with access to cutting-edge research, expertise, and talent. By partnering with academic institutions, AIFarm can accelerate its innovation efforts, validate its technologies, and gain credibility in the market. These partnerships can also lead to joint projects, funding opportunities, and access to a pipeline of skilled graduates. Many universities have established agricultural research programs focused on sustainable farming practices and innovative technologies.
- Focus on Vertical Farming Applications: AIFarm can specialize in designing and building biodomes for vertical farming applications, which involve growing crops in vertically stacked layers. Vertical farming offers several advantages, including higher yields, reduced land usage, and lower water consumption. By targeting the vertical farming market, AIFarm can cater to urban areas and regions with limited space for traditional agriculture. The global vertical farming market is projected to reach $19.86 billion by 2030, driven by factors such as urbanization, population growth, and the need for local food production.
- Offering Comprehensive Training and Support Services: In addition to designing and building biodomes, AIFarm can provide comprehensive training and support services to its customers. This includes training on biodome operation, crop management, and pest control. By offering ongoing support, AIFarm can ensure that its customers are successful in using its biodomes and can maximize their crop yields. This can also lead to increased customer loyalty and repeat business. Many agricultural technology companies offer training and support services to help their customers adopt new technologies and improve their farming practices.
What Opportunities Does AIFM Have?
- Expansion into new geographic markets
- Development of advanced biodome technologies
- Partnerships with research institutions and universities
- Focus on vertical farming applications
What Threats Does AIFM Face?
- Intense competition from established agricultural technology companies
- Economic downturns that could reduce demand for agricultural investments
- Changes in government regulations related to agriculture and environmental sustainability
- Technological advancements that could render AIFarm's solutions obsolete
What Are AIFM's Competitive Advantages?
- Proprietary growing system design
- Customization capabilities for diverse client needs
- Focus on sustainable and efficient agricultural practices
What Does AIFM Do?
Founded in 2012, AIFarm, Ltd., formerly known as Eco Energy Tech Asia, Ltd. until its name change in January 2020, is a development stage company specializing in the design and construction of custom biodomes. Headquartered in Kowloon, Hong Kong, AIFarm targets both commercial agricultural concerns and small local producers, offering a proprietary growing system tailored to their specific needs. The company's core business revolves around creating controlled environment agriculture (CEA) solutions through its biodomes, enabling year-round crop production, resource efficiency, and reduced environmental impact. AIFarm's biodomes are designed to optimize growing conditions, including temperature, humidity, and light, to maximize yields and minimize resource consumption. While still in the development stage, AIFarm aims to expand its global footprint by providing sustainable and efficient agricultural solutions to a diverse range of clients.
What Products and Services Does AIFM Offer?
- Designs and builds custom biodomes for agricultural purposes.
- Develops proprietary growing systems.
- Caters to commercial agricultural concerns.
- Serves small local producers.
- Offers controlled environment agriculture (CEA) solutions.
- Optimizes growing conditions within biodomes.
How Does AIFM Make Money?
- Generates revenue through the design and construction of custom biodomes.
- Offers proprietary growing systems tailored to client needs.
- Potentially generates revenue through ongoing support and maintenance services.
What Industry Does AIFM Operate In?
AIFarm, Ltd. operates within the agricultural machinery industry, which is experiencing increased demand for innovative and sustainable solutions. The global agricultural machinery market is projected to grow, driven by factors such as increasing population, rising food demand, and the need for efficient farming practices. Companies like AIFarm that offer specialized solutions such as biodomes are positioned to capitalize on this trend. However, the industry is also highly competitive, with established players and emerging startups vying for market share. AIFarm's success will depend on its ability to differentiate itself through technological innovation, cost-effectiveness, and strong customer relationships.
Who Are AIFM's Key Customers?
- Commercial agricultural businesses
- Small local agricultural producers
- Organizations seeking sustainable agriculture solutions
How AIFarm, Ltd. Is Valued
AIFarm, Ltd. carries a market capitalization of 2K, placing it in the micro-cap category. Relative to its peer group, AIFM's quantitative score of 46/100 is roughly in line with the peer average of 55/100.
Company Profile
AIFarm, Ltd. operates in the Agricultural - Machinery industry within the Industrials sector. It is headquartered in Kowloon, HK. The company is led by CEO Yuen May Cheung. AIFM has traded publicly since 2016.
ROE 29%Key Financial Metrics
Return on equity for AIFarm, Ltd. stands at 28.8%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.03 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 0/9Financial Health
AIFarm, Ltd.'s Piotroski F-Score is 0/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
AIFM Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Proprietary biodome design and construction expertise
- Customization capabilities to meet diverse client needs
- Focus on sustainable and efficient agricultural practices
- Potential to capitalize on the growing demand for CEA solutions
Bear Case
- Development stage company with limited operating history
- Reliance on future funding to support growth
- Small team size and limited resources
- Lack of established brand recognition
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
AIFM Latest News
No recent news available for AIFM.
AIFM Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AIFM.
Price Targets
Wall Street price target analysis for AIFM.
AIFM MoonshotScore
What does this score mean?
The MoonshotScore rates AIFM's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Yuen May Cheung
Managing Director
Yuen May Cheung is the Managing Director of AIFarm, Ltd. and oversees the company's operations with a team of three employees. Information on Cheung's prior experience and educational background is not available. As the head of a development stage company, Cheung's role is critical in shaping the company's strategic direction and securing funding for future growth. Cheung's leadership will be instrumental in navigating the challenges and opportunities in the emerging biodome market.
Track Record: Due to AIFarm's status as a development stage company, there is limited information available regarding Yuen May Cheung's track record. Cheung's primary focus has been on establishing the company's foundation, developing its proprietary growing system, and securing initial clients. The success of AIFarm will depend on Cheung's ability to execute the company's business plan and achieve sustainable growth.
AIFM OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that AIFarm, Ltd. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be required to provide regular financial disclosures. Investing in companies on the OTC Other tier carries a higher degree of risk compared to those listed on major exchanges like the NYSE or NASDAQ due to the lack of regulatory oversight and transparency. Investors should conduct thorough due diligence before investing in OTC Other stocks.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosures and transparency
- Low trading volume and liquidity
- Higher risk of price manipulation
- Potential for delisting or suspension of trading
- Limited regulatory oversight
- Verify the company's registration and legal status
- Review available financial statements and disclosures
- Assess the company's business model and competitive landscape
- Evaluate the management team and their track record
- Understand the risks associated with investing in OTC stocks
- Consult with a financial advisor before making any investment decisions
- Company registration and legal compliance
- Existence of a website and contact information
- Press releases and media coverage
- Partnerships with reputable organizations
- Positive customer reviews or testimonials
AIFarm, Ltd. Industrials Stock: Key Questions Answered
What does AIFarm, Ltd. do?
AIFarm, Ltd. is a development stage company that specializes in designing and building custom biodomes for agricultural purposes. These biodomes are tailored to meet the specific needs of both commercial agricultural operations and smaller, local producers. AIFarm's proprietary growing systems aim to optimize growing conditions, enabling year-round crop production and efficient resource utilization. The company focuses on providing sustainable and innovative solutions to address the growing demand for controlled environment agriculture (CEA) worldwide.
What do analysts say about AIFM stock?
As of March 18, 2026, there are no readily available analyst ratings or price targets for AIFarm, Ltd. (AIFM). This is likely due to the company's status as a development stage company trading on the OTC market, which typically receives less analyst coverage than larger, exchange-listed companies. Investors should conduct their own thorough research and consider the risks associated with investing in a development stage company before making any investment decisions. Key valuation metrics such as revenue growth, profitability, and cash flow are not yet established for AIFarm, Ltd.
What are the main risks for AIFM?
AIFarm, Ltd. faces several key risks typical of development stage companies in the agricultural machinery sector. These include limited operating history, reliance on securing future funding, and intense competition from established players. The company's success depends on its ability to execute its business plan, develop innovative technologies, and gain market share. Additionally, AIFarm is subject to risks related to economic downturns, changes in government regulations, and technological advancements that could render its solutions obsolete. Investing in AIFarm, Ltd. carries a high degree of risk and is suitable only for investors with a high-risk tolerance.
What are the key factors to evaluate for AIFM?
AIFarm, Ltd. (AIFM) holds an AI score of 46/100 (low). Not financial advice.
How frequently does AIFM data refresh on this page?
AIFM prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven AIFM's recent stock price performance?
AIFarm, Ltd. (AIFM) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary biodome design and construction expertise. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider AIFM overvalued or undervalued right now?
Valuing AIFarm, Ltd. (AIFM) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying AIFM?
Before investing in AIFarm, Ltd. (AIFM), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is limited due to the company's development stage and OTC listing.
- Financial data is based on available information and may not be comprehensive.